Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug resistance in hematologic malignancies.

J P Marie1

  • 1Department of Hematology and Medical Oncology, University Paris 6, Paris, France. jean-pierre.marie@htd.ap-hop-paris.fr

Current Opinion in Oncology
|October 24, 2001
PubMed
Summary

Drug resistance in hematologic malignancies is a major challenge. New strategies target multiple drug efflux pumps and utilize novel drug formulations to overcome chemotherapy resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Audiological phenotyping evaluation in KBG syndrome: Description of a multicenter review.

International journal of pediatric otorhinolaryngology·2023
Same author

Ruptured dural arteriovenous fistula and sinus venous thrombosis following surgical resection of a vestibular schwannoma: Case report and review of the literature.

Neuro-Chirurgie·2022
Same author

[Vocal cord dysfunction in athletes: Interest of rehabilitation to effort].

Revue des maladies respiratoires·2021
Same author

Stapes surgery in osteogenesis imperfecta: retrospective analysis of 18 operated ears.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2021
Same author

Alteration of Swallowing and Ventilation Coordination in Respiratory Diseases in Small Mammals.

Dysphagia·2019
Same author

Treatment of unilateral vocal fold paralysis with ansa cervicalis to recurrent nerve anastomosis in a young adolescent: European case report.

The Journal of laryngology and otology·2018

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Drug resistance is a significant clinical problem in hematologic malignancies treated with chemotherapy.
  • Mechanisms include overexpression of ATP-binding cassette (ABC) transporters (P-gp, MRPs, BCRP), enzyme modifications, and impaired apoptosis.
  • Current strategies primarily focus on P-glycoprotein (P-gp) modulation.

Purpose of the Study:

  • To review the mechanisms of chemotherapy drug resistance in hematologic malignancies.
  • To discuss emerging strategies for overcoming drug resistance, including multi-target modulators and novel drug delivery systems.

Main Methods:

  • Review of existing literature on drug resistance mechanisms in hematologic malignancies.
  • Analysis of current and emerging therapeutic strategies targeting ABC transporters.
  • Discussion of novel drug formulations like liposomal and nanoparticular anthracyclines.

Main Results:

  • P-glycoprotein (P-gp) inhibition has been a primary focus, with compounds like PSC833 completing Phase III trials.
  • Development of multi-target modulators (e.g., GG120918, VX710) inhibiting multiple ABC transporters (P-gp, BCRP, MRPs) shows clinical promise.
  • Alternative approaches involve "furtive" drug delivery systems, such as liposomal or nanoparticular anthracyclines.

Conclusions:

  • Overcoming drug resistance in hematologic malignancies requires addressing multiple resistance mechanisms simultaneously.
  • Multi-target ABC transporter inhibitors and innovative drug delivery systems represent promising avenues for improving treatment efficacy.
  • Further research into these strategies is crucial for clinical application in treating resistant hematologic cancers.

Related Experiment Videos